Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale

In 2024, medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale trade exhibited slight decline, with global flows reaching $489,633,972 and a three-year compound annual growth rate of -25.4% (five-year: -19.1%). The all-time peak of $3,583,781,164 was recorded in 2008; the current level is 86% below that high-water mark.

Over the 30-year observation window (1995–2024), 62% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is decelerating (-10.7% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.198). The three largest exporters — India ($223.9M), China ($131.0M), and Denmark ($109.1M) — collectively dominate supply flows. The leading exporter has grown at -8.4% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.062). The three largest import markets are Sweden ($68.0M), Nigeria ($61.0M), and France ($59.3M). The largest importing market sources from 16 different supplying countries.

The dominant trade corridor is Denmark → Sweden at $36.4M, representing 53.5% of the importer's total demand.

The volatility score for medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale is 2 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.